[Cyclophosphamide and bladder carcinoma (case report) (author's transl)]

A bladder carcinoma developed in a 40-year-old man who was being treated with trofosfamide (Ixoten), a cyclophosphamide derivative, for Hodgkin's disease. The case suggests the need for differentiated replacement of this group of cytostatics.